scPharmaceuticals Inc. (SCPH)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 149.27M |
| Enterprise value | 131.62M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 9.11 |
| Price/book (mrq) | 6.08 |
| Enterprise value/revenue | 7.46 |
| Enterprise value/EBITDA | -6.69 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.07 |
| 52-week change 3 | -62.23% |
| S&P500 52-week change 3 | 23.76% |
| 52-week high 3 | 11.0500 |
| 52-week low 3 | 3.2400 |
| 50-day moving average 3 | 4.3895 |
| 200-day moving average 3 | 5.5041 |
Share statistics
| Avg vol (3-month) 3 | 236.57k |
| Avg vol (10-day) 3 | 292.64k |
| Shares outstanding 5 | 36.05M |
| Implied shares outstanding 6 | 36.05M |
| Float 8 | 16.19M |
| % held by insiders 1 | 11.65% |
| % held by institutions 1 | 75.62% |
| Shares short (15 May 2024) 4 | 4.76M |
| Short ratio (15 May 2024) 4 | 24.74 |
| Short % of float (15 May 2024) 4 | 15.72% |
| Short % of shares outstanding (15 May 2024) 4 | 13.21% |
| Shares short (prior month 15 Apr 2024) 4 | 4.78M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -259.85% |
Management effectiveness
| Return on assets (ttm) | -36.26% |
| Return on equity (ttm) | -114.99% |
Income statement
| Revenue (ttm) | 17.63M |
| Revenue per share (ttm) | 0.45 |
| Quarterly revenue growth (yoy) | 195.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -59.67M |
| Net income avi to common (ttm) | -57.71M |
| Diluted EPS (ttm) | -1.4800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 58.98M |
| Total cash per share (mrq) | 1.64 |
| Total debt (mrq) | 40.8M |
| Total debt/equity (mrq) | 166.09% |
| Current ratio (mrq) | 6.21 |
| Book value per share (mrq) | 0.68 |
Cash flow statement
| Operating cash flow (ttm) | -60.45M |
| Levered free cash flow (ttm) | -40.04M |
© 2024 Yahoo. All rights reserved.